Results 101 to 110 of about 416,662 (279)
Neuropsychiatric Disease and Treatment, 2020 Carolin Hoyer, Niklas Grassl, Kathrin Bail, Patrick Stein, Anne Ebert, Michael Platten, Kristina Szabo Department of Neurology, Medical Faculty Mannheim and Mannheim Center for Translational Neurosciences (MCTN), Heidelberg University, Mannheim ...
Hoyer C +6 more
doaj
International Journal of Cancer, EarlyView.What's New? This study is the first to quantify the cost‐effectiveness of breast cancer treatment in German Cancer Society‐certified hospitals using real‐world data from over 140,000 patients. Analysis on certification‐related costs and survival outcomes demonstrates that high‐quality multidisciplinary care at certified hospitals delivers substantial ...
Min‐Wai Lwin +20 more
wiley +1 more source
Position and the development of the global steel industry [PDF]
Metalurgija, 2008 In the article, the view to the position and development of the global steel industry is commented using the experience of last 20 years of evolution of the Czech steel industry. The changes are observed in the scope of production, consumption, and trade.
J. Raab, J. Mannheim
doaj
International Journal of Cancer, EarlyView.What's New? Oxaliplatin serves a key role in the treatment of rectal cancer, though it is a significant cause of chemotherapy‐induced peripheral neuropathy. As total neoadjuvant therapy, in which all therapy is given before surgery, has become more common, understanding neuropathy has grown increasingly important. This study examined neuropathy and its
Georg W. Wurschi +29 more
wiley +1 more source
THE LEGACY OF HISTORISM IN THE MANNHEIM’S SOCIOLOGY OF KNOWLEDGE
Истраживања, 2012 The main goal of this paper is problematization of idea of historism through the ideas of Karl Mannheim (especially on the ideology and vision of the world).
Dušan Marinković, Dušan Ristić
doaj
International Journal of Cancer, EarlyView.What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching +20 more
wiley +1 more source
International Journal of Cancer, EarlyView.What's New? Although patients with melanoma brain metastases (MBM) may benefit from treatment with immune checkpoint inhibitors (ICIs), which are known to improve survival in advanced melanoma, MBM patients have often been excluded from trials evaluating ICIs.
Ralf Gutzmer +18 more
wiley +1 more source
International Journal of Cancer, EarlyView.What's New? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas +13 more
wiley +1 more source
International Journal of Cancer, EarlyView.Although immune checkpoint inhibitors (ICI) have transformed metastatic melanoma treatment, thromboembolic events (TEEs) remain a serious complication. Moreover, existing risk assessment models were developed prior to ICI use and lack clinical validation.
Tim Zell +12 more
wiley +1 more source
International Journal of Cancer, EarlyView.Optimizing neoadjuvant therapy for muscle‐invasive bladder cancer patients who are eligible for cisplatin remains difficult, owing particularly to high toxicity and recurrence rates. This meta‐analysis compared dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) against durvalumab plus gemcitabine‐cisplatin (D‐GC) and GC alone ...
Maurin Helen Mangold +12 more
wiley +1 more source